Bank Of New York Mellon Corp Karyopharm Therapeutics Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$2.48 - $5.93 $1.07 Million - $2.57 Million	432,881 New	432,881 $1.47 Million
Q3 2022 Nov 14, 2022	BUY	$4.08 - $5.82 $51,448 - $73,390	12,610 Added 4.4%	298,991 $1.63 Million
Q2 2022 Aug 15, 2022	SELL	$4.15 - $8.37 $43,653 - $88,044	-10,519 Reduced 3.54%	286,381 $1.29 Million
Q1 2022 May 11, 2022	SELL	$5.91 - $14.38 $3,788 - $9,217	-641 Reduced 0.22%	296,900 $2.19 Million
Q4 2021 Feb 11, 2022	SELL	$5.21 - $8.61 $25,841 - $42,705	-4,960 Reduced 1.64%	297,541 $1.91 Million
Q3 2021 Nov 12, 2021	BUY	$4.45 - $10.63 $59,830 - $142,920	13,445 Added 4.65%	302,501 $1.76 Million
Q2 2021 Aug 11, 2021	SELL	$8.11 - $11.11 $248,993 - $341,099	-30,702 Reduced 9.6%	289,056 $2.98 Million
Q1 2021 May 13, 2021	SELL	$9.85 - $17.69 $90,639 - $162,783	-9,202 Reduced 2.8%	319,758 $3.36 Million
Q4 2020 Feb 09, 2021	SELL	$14.15 - $17.19 $248,374 - $301,736	-17,553 Reduced 5.07%	328,960 $5.09 Million
Q3 2020 Nov 12, 2020	BUY	$14.14 - $19.71 $374,695 - $522,295	26,499 Added 8.28%	346,513 $5.06 Million
Q2 2020 Aug 12, 2020	SELL	$16.6 - $25.25 $123,255 - $187,481	-7,425 Reduced 2.27%	320,014 $6.06 Million
Q1 2020 May 06, 2020	BUY	$14.38 - $27.72 $522,655 - $1.01 Million	36,346 Added 12.49%	327,439 $6.29 Million
Q4 2019 Feb 14, 2020	BUY	$9.23 - $19.67 $468,939 - $999,354	50,806 Added 21.14%	291,093 $5.58 Million
Q3 2019 Nov 07, 2019	BUY	$5.66 - $11.85 $48,942 - $102,466	8,647 Added 3.73%	240,287 $2.31 Million
Q2 2019 Aug 12, 2019	BUY	$4.32 - $6.43 $54,699 - $81,416	12,662 Added 5.78%	231,640 $1.39 Million
Q1 2019 May 14, 2019	BUY	$4.12 - $10.25 $2,331 - $5,801	566 Added 0.26%	218,978 $1.28 Million
Q4 2018 Feb 11, 2019	SELL	$8.2 - $16.95 $1,492 - $3,084	-182 Reduced 0.08%	218,412 $2.05 Million
Q3 2018 Nov 09, 2018	BUY	$17.03 - $21.18 $77,929 - $96,919	4,576 Added 2.14%	218,594 $0
Q2 2018 Aug 06, 2018	BUY	$12.0 - $19.88 $562,932 - $932,590	46,911 Added 28.07%	214,018 $3.64 Million
Q1 2018 May 15, 2018	BUY	$9.92 - $17.25 $39,818 - $69,241	4,014 Added 2.46%	167,107 $2.24 Million
Q4 2017 Feb 09, 2018	BUY	$9.15 - $11.99 $1.49 Million - $1.96 Million	163,093	163,093 $1.57 Million

Others Institutions Holding KPTI

# of Institutions

Shares Held

56.5M

Call Options Held

258K

Put Options Held

81.2K

Vanguard Group Inc Valley Forge, PA

7.65M
Shares

$4.75 Million
0.0% of portfolio
Eversept Partners, LP New York, NY

5.55M
Shares

$3.44 Million
0.36% of portfolio
Palo Alto Investors LP Palo Alto, CA

5.1M
Shares

$3.16 Million
0.58% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

4.32M
Shares

$2.68 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.17M
Shares

$2.59 Million
0.0% of portfolio

View Full List

About Karyopharm Therapeutics Inc.

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $49.5M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

More about KPTI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account